secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182569
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor to buy Rotech for $1.36B cash; expects ~$0.15 EPS accretion in second year
--------------------------------------------------------------------------------

- Purchase price $1.36B cash; net $1.32B after ~$40M tax benefits; ~6.3x LTM EBITDA ex-synergies.
- Rotech 2023 revenue ~$750M with ~30% EBITDA margin; 4,200+ employees, ~325 locations in 46 states.
- Expected close by end of 2024; subject to HSR; financed with $775M term loan B and $625M bridge.
- Synergies ~$50M by end of year three; adjusted EPS neutral in first full year, accretive in second year.
- Owens & Minor reaffirms 2024 full-year guidance; preliminary Q2 results reported separately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/0001193125-24-182569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/d861390d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer